Anúncio
Anúncio
LEGN
Legend Biotech Corporation - ADR
21.51
USDPatrocinado
-0.23
-1.07%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
21.57
+0.07
+0.31%
Relatórios de Lucros LEGN
Rácio de surpresa positiva
LEGN separação 9 de 20 últimas estimativas.
45%
Próximo Relatório
Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$321.79M
/-$0.08
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+18.16%
/-63.64%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+72.52%
/-153.33%
Legend Biotech Corporation - ADR earnings per share and revenue
On 12 de nov. de 2025, LEGN reported earnings of -0.22 USD per share (EPS) for Q3 25, missing the estimate of -0.08 USD, resulting in a -155.52% surprise. Revenue reached 272.33 milhão, compared to an expected 277.95 milhão, with a -2.02% difference. The market reacted with a -2.67% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analistas forecast an EPS of -0.08 USD, with revenue projected to reach 321.79 milhão USD, implying an diminuir of -63.64% EPS, and aumentar of 18.16% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Legend Biotech Corporation - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Legend Biotech Corporation - ADR reported EPS of -$0.22, missing estimates by -155.52%, and revenue of $272.33M, -2.02% below expectations.
How did the market react to Legend Biotech Corporation - ADR's Q3 2025 earnings?
The stock price moved down -2.67%, changed from $32.03 before the earnings release to $31.18 the day after.
When is Legend Biotech Corporation - ADR expected to report next?
The next earning report is scheduled for 09 de mar. de 2026.
What are the forecasts for Legend Biotech Corporation - ADR's next earnings report?
Based on 18
analistas, Legend Biotech Corporation - ADR is expected to report EPS of -$0.08 and revenue of $321.79M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio